Myriad Genetics, Inc. (MYGN) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Myriad Genetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.758 Good day and thank you for standing by. Welcome to the Marriott Genetics Second Quarter 00:00:04.758 -- 00:00:10.065 2025 Financial Earnings Conference Call. At this time, all participants 00:00:10.065 -- 00:00:14.712 are in a listen-only mode. After the speaker's presentation, there will be a question 00:00:14.712 -- 00:00:19.178 and answer session. To ask a question during the session, you will need to press star 00:00:19.178 -- 00:00:24.425 1-1 on your telephone. You will then hear an automated message advising your hand 00:00:24.425 -- 00:00:29.972 is raised. To withdraw your question, please press star 11 again. 00:00:29.972 -- 00:00:33.836 Please be advised that today's conference is being recorded. 00:00:33.836 -- 00:00:37.260 I would now like to hand the conference over to your speaker today. 00:00:37.260 -- 00:00:39.542 Matt Scallo, please go ahead. 00:00:39.542 -- 00:00:41.542 Good 00:00:42.866 -- 00:00:47.971 afternoon, and welcome to the Mary Genetics second quarter 2025 earnings call. 00:00:47.971 -- 00:00:52.616 During the call, we will review the financial results we released today, and afterwards, 00:00:52.616 -- 00:00:57.458 we will host a Q&A session. Our quarterly earnings release was issued this afternoon 00:00:57.458 -- 00:01:03.063 on Form 8K and can be found on our website at Investor.myriad.com. 00:01:03.325 -- 00:01:07.771 I'm Matt Scalo, Senior Vice President of Investor Relations, and on the call with me 00:01:07.771 -- 00:01:12.937 today are Sam Raha, our President and Chief Executive Officer, Scott Loeffler, 00:01:12.937 -- 00:01:17.863 our Chief Financial Officer, and Mark Verratti, our Chief Operating Officer. 00:01:17.863 -- 00:01:22.466 This call can be heard live via webcast at Investor.myriad.com....